Research Reports
Sales of Vitamin E derivatives will Expand at a CAGR of 3.4% over the Forecast Period 2026
According to a new report published by Fact.MR, the global sales of vitamins and derivatives is expected to surpass 165,000 tons by the end of…
Published : 3 years ago, on
According to a new report published by Fact.MR, the global sales of vitamins and derivatives is expected to surpass 165,000 tons by the end of 2026 in terms of volume. During the forecast period (2017-2026), the market is projected to exhibit a CAGR of 3.5% in term of value. Rising health awareness among consumers, increasing demand for healthy and functional food, expanding geriatric population are some of important factors likely to influence the global consumption of vitamins and derivatives during the review period. Moreover, increased demand for products with higher nutritional content is expected to reflect favorably on the market. In has been observed that, use of vitamin supplements has grown notably in the countries such as Brazil, China, Philippines and India, which has propelled the market further.
To remain ‘ahead’ of your competitors, request a sample
https://www.factmr.com/connectus/sample?flag=S&rep_id=380
Fact.MR has adopted multi-disciplinary approach to shed light on the evolution of the Vitamins and Derivatives Market during the historical period. The study presents a deep-dive assessment of the current growth dynamics, major avenues in the estimation year of 2019, and key prospects over the forecast period 2017 to 2026. The insights and analytics on the Vitamins and Derivatives Market span several pages. These are covered in numerous sections, including, drivers and restraints, challenges and opportunities, regional segmentation and opportunity assessment, end-use/application prospects analysis, and competitive landscape assessment.
Key producers of cocoa liquor have been profiled in the report
- Amway
- Herbalife
- Glanbia PLC
- ADM
- DSM
- Abott Laboratories
- GlaxoSmithKline
- Glanbia
- Bayer
Key Insights from the Report Include:
- Based on target group, the adult women segment is expected to hold its dominant position over 2026. The segment currently represents for more than 51% revenue share of the global market and expected to exhibit a CAGR of 2.8% during the assessment period
- Consumption of vitamins and derivatives is relatively higher among adult women. This is primarily owing to a greater need for nutrition in adult women. Moreover, women all over the world are becoming increasingly conscious about their health and wellbeing.
- Among regions, North America is expected to dominate the global vitamins and derivatives market in 2018, and the trend is likely to continue throughout the forecast period.
- On the basis of product type, the Vitamin B segment is expected to remain highly attractive in 2018 and beyond. Currently, the segment is command for over one-fourth revenue share of the global market and expected to reach a market valuation in excess of US$ 7,300 Mn by the 2026. Over the course the forecast period, the segment is anticipated to grow by US$ 297.7 Mn annually.
- On the basis of end use industry, the food and beverage segment is likely to retain its top position over 2026. By the end of 2026, this segment is estimated to surpass a market valuation of US$ 6,900 Mn, reflecting an above-average CAGR.
After reading the Vitamins and Derivatives Market report, readers get insight into:
- Major drivers and restraining factors, opportunities and challenges, and the competitive landscape
- New, promising avenues in key regions
- New revenue streams for all players in emerging markets
- Focus and changing role of various regulatory agencies in bolstering new opportunities in various regions
- Demand and uptake patterns in key industries of the Vitamins and Derivatives Market
- New research and development projects in new technologies in key regional markets
- Changing revenue share and size of key product segments during the forecast period 2017 to 2026
- Technologies and business models with disruptive potential
Market Players
Region |
|
Product Type |
|
Target Group |
|
End Use Industries |
|
Form |
|
Regional analysis includes
- North America (U.S., Canada)
- Latin America (Brazil, Mexico, Argentina, Chile, Peru, Rest of LATAM)
- EU – (Germany, France, Italy, Spain), UK, BENELUX (Belgium, Netherlands, Luxemburg), NORDIC (Norway, Denmark, Iceland, Sweden), Eastern Europe (Poland, Ukraine, Czech Rep. etc.), Rest of Europe
- CIS & Russia
- Japan
- Asia Pacific Excluding Japan (Greater China, India, S. Korea, ASEAN Countries, Rest of APEJ)
- Middle East and Africa (GCC Countries, Turkey, Iran, Israel, South Africa , Rest of MEA)
Get Access To Research Methodology Prepared By Experts
https://www.factmr.com/connectus/sample?flag=RM&rep_id=380
The Report Covers Exhaustive Analysis On:
- Market Segments
- Market Dynamics
- Market Size & Demand
- Current Trends/Issues/Challenges
- Competition & Companies involved
- Technology
- Value Chain
The global Vitamins and Derivatives market report offers detailed assessments and quantitative evaluations that shed light on numerous key aspects that have shaped its evolution over the historical period. In coming years, some of the key aspects that will shape the growth prospects during the forecast period are objectively covered in the study.
Some important questions that the Vitamins and Derivatives Market report tries to answer exhaustively are:
- Key strategic moves by various players in the Vitamins and Derivatives Market in recent years with respect to product launches, deals and tie-ups, and mergers and acquisitions, and divestment of shares
- Which strategies will enable top players in the Vitamins and Derivatives Market to expand their geographic footprints
- Which new business models are expected to change the course of growth of key regional markets in near future
- Which technologies will witness most attractive research investments and what will be the key sources of funding for startups and new entrants
- Which products segments have in recent years have seen new, lucrative application areas
Benefits of Fact.MR Study
Fact.MR has gradually established itself as one of the leading market research companies across the globe. Our unique, methodical, and up-to-date approach towards creating high-quality market reports ensures the reports include relevant market insights. Further, our team of analysts leaves no stone unturned while curating market reports in accord with the requirement of our clients.
Why Choose Fact.MR?
- Deliver updated information on the current industry trends
- Available 24/7 to facilitate clients with unbiased solutions
- Embrace digital technologies to offer accurate business ideas
- Exhaustive supply chain augmentation analysis
- Provide reports strictly according to the requirements of the clients
About Fact.MR
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in the US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have in our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.
Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
E: [email protected]
Website: https://www.factmr.com
-
Interviews4 days ago
Fosun International: The Hidden Gem Ready to Shine – Co-CEO Chen Qiyu on Unlocking True Value for Investors
-
Banking4 days ago
What Banks Need to Know About Adopting Custom Financial Software Solutions
-
Finance4 days ago
How Close Are We to G20 Cross-Border Goals?
-
Top Stories4 days ago
Italgas sees double-digit income growth to 2030, ups minimum dividend rise